tiprankstipranks
UCB SA (GB:0NZT)
LSE:0NZT

Compare UCB SA (0NZT) vs. Competitors

16 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€273.32
€52.06B
10.46
99.75%
6 Buy
2 Hold
0 Sell
Strong Buy
AstraZeneca
14918.00 p
£232.44B
28.13
44.55%
13 Buy
2 Hold
1 Sell
Strong Buy
GlaxoSmithKline
2190.00 p
£86.70B
12.93
65.60%
3 Buy
7 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1554.00 p
£2.85B
11.21
-28.30%
2 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0NZT
UCB SA
273.32
135.32
98.05%
GB:AZN
AstraZeneca
14,918.00
4,839.65
48.02%
GB:GSK
GlaxoSmithKline
2,190.00
897.04
69.38%
GB:HIK
Hikma Pharmaceuticals
1,340.00
-471.17
-26.01%
GB:INDV
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts